Category: Zacks Small Cap Research

12348820 / 874 POSTS
By Lisa ThompsonOTC:POETF | TSX:PTK.V READ THE FULL POETF RESEARCH REPORT The Holy Grail in photonics is cost reduction (through efficiencies in process and materials) combined with lower power consumption. Throw in a smaller size, and higher perform ...
By John Vandermosten, CFANASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Initiating Coverage We are initiating coverage of DarioHealth, Corp. (NASDAQ:DRIO) with a current valuation of $10.50 per share. This present value is based on our estimates for ...
By Beth Senko, CFAOTC:UCASU READ THE FULL UCASU RESEARCH REPORT With so much uncertainty in the world, looking at one’s investments, much less thinking about where to invest, might be towards the bottom of many people’s “things to do while staying in ...
By Zacks Small-Cap ResearchOTC:JMDA READ THE FULL JMDA RESEARCH REPORT Jerrick Media (OTC:JMDA) is still in the process of raising capital to support operating expenses and shore up its balance sheet ahead of its planned uplisting to the Nasdaq capit ...
By John Vandermosten, CFANASDAQ:DYAI On July 8, 2020, Dyadic (NASDAQ:DYAI) announced the successful addition of two, fully funded collaborations with global animal health companies to study whether it is feasible for Dyadic’s fungal protein expressio ...
By David Bautz, PhDNASDAQ:BCLI READ THE FULL BCLI RESEARCH REPORT Business Update KOL Event for Alzheimer’s Program On July 8, 2020, BrainStorm Cell Therapeutics, Inc. (NASDAQ:BCLI) conducted a Key Opinion Leader (KOL) webinar to discuss the company’ ...
By Brian Marckx, CFANASDAQ:MTBC READ THE FULL MTBC RESEARCH REPORT MTBC Makes Largest Acquisition To-Date. Meridian Medical Mgmt Co Purchase Closed June 16th MTBC, Inc. (NASDAQ:MTBC) made its largest acquisition to-date, closing on its purchase of Me ...
By David Bautz, PhDTSX:APLI.V READ THE FULL APLI.V RESEARCH REPORT Business Update Appili Therapeutics Inc. (TSX:APLI.V) is a biopharmaceutical company devoted to acquiring and developing novel treatments for infectious diseases. The company was foun ...
By David Bautz, PhDNASDAQ:MNOV READ THE FULL MNOV RESEARCH REPORT Business Update FDA Approves Clinical Plan for MN-166 to Prevent ARDS Caused by COVID-19 On July 1, 2020, MediciNova, Inc. (NASDAQ:MNOV) announced that the company’s Investigational Ne ...
By Ann Heffron, CFA, CPAOTC:CPKF READ THE FULL CPKF RESEARCH REPORT Chesapeake Financial's (OTC:CPKF) first quarter net earnings rose $0.4 million, or 13%, year over year to $3.4 million, while 2020’s first quarter diluted EPS increased by $0.08, or ...
12348820 / 874 POSTS